Elanco Animal Health Incorporated revised earnings guidance for the year 2022. For the year, Revenue of $4,385 million to $4,430 million against previous guidance of $4,465 million to $4,550 million and Reported LPS of $0.17 to $0.12 against previous guidance of $0.10 to $0.03.